Foundation Medicine (NASDAQ: FMI) reported Q4 EPS of ($0.47), $0.04 better than the analyst estimate of ($0.51). Revenue for the quarter came in at $18.7 million versus the consensus estimate of $18.05 million.

For earnings history and earnings-related data on Foundation Medicine (FMI) click here.